Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Bartolucci

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Presse Medicale (Paris, France : 1983)|February 9, 2007
[Treatment trial methodology in internal medicine]Isabelle Mahé, Antoine Bosquet, Pablo Bartolucci, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|March 25, 2019
Intracranial aneurysms in sickle cell disease: Aneurysms characteristics and modalities of endovascular approach to treat these patientsSophie Gallas, Titien Tuilier, Vahid Ebrahiminia, et al.
American Journal of Hematology|September 13, 2007
Successful treatment with rituximab in a patient with an acquired factor V inhibitorAgnes Lebrun, Catherine Leroy-Matheron, Jean-Benoit Arlet, et al.
Haematologica|January 13, 2022
Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysisJulien Lopinto, Segolene Gendreau, Enora Berti, et al.
Blood Advances|March 2, 2021
Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patientsMarie Tamagne, Sadaf Pakdaman, Pablo Bartolucci, et al.
Stroke|July 16, 2015
First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?David Calvet, Françoise Bernaudin, Antoine Gueguen, et al.
Haematologica|May 8, 2025
Evaluating the safety profile of defibrotide in sickle cell disease: an in vitro studyLaura Bencheikh, Meghan Perkins, Kim Anh Nguyen, et al.
Biomolecules|July 2, 2021
Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease EventsPhilippe Chadebech, Gwellaouen Bodivit, Gaétana Di Liberto, et al.
Blood|April 26, 2022
Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell diseaseOndine Walter, Pierre Cougoul, Julien Maquet, et al.
Blood|August 25, 2012
Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysisPablo Bartolucci, Carlo Brugnara, Armando Teixeira-Pinto, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Presse Medicale (Paris, France : 1983)|February 9, 2007
[Treatment trial methodology in internal medicine]Isabelle Mahé, Antoine Bosquet, Pablo Bartolucci, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|March 25, 2019
Intracranial aneurysms in sickle cell disease: Aneurysms characteristics and modalities of endovascular approach to treat these patientsSophie Gallas, Titien Tuilier, Vahid Ebrahiminia, et al.
American Journal of Hematology|September 13, 2007
Successful treatment with rituximab in a patient with an acquired factor V inhibitorAgnes Lebrun, Catherine Leroy-Matheron, Jean-Benoit Arlet, et al.
Haematologica|January 13, 2022
Effects of corticosteroids in patients with sickle cell disease and acute complications: a systematic review and meta-analysisJulien Lopinto, Segolene Gendreau, Enora Berti, et al.
Blood Advances|March 2, 2021
Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patientsMarie Tamagne, Sadaf Pakdaman, Pablo Bartolucci, et al.
Stroke|July 16, 2015
First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?David Calvet, Françoise Bernaudin, Antoine Gueguen, et al.
Haematologica|May 8, 2025
Evaluating the safety profile of defibrotide in sickle cell disease: an in vitro studyLaura Bencheikh, Meghan Perkins, Kim Anh Nguyen, et al.
Biomolecules|July 2, 2021
Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease EventsPhilippe Chadebech, Gwellaouen Bodivit, Gaétana Di Liberto, et al.
Blood|April 26, 2022
Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell diseaseOndine Walter, Pierre Cougoul, Julien Maquet, et al.
Blood|August 25, 2012
Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysisPablo Bartolucci, Carlo Brugnara, Armando Teixeira-Pinto, et al.
Pageof 13